Waters raised to Outperform at Wolfe on BD Life Sciences deal
Source: SeekingAlpha
2025-12-10 11:29:33 ET
More on Waters, Becton, Dickinson
- Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript
- Becton, Dickinson: Our New, Long, Special Situation Investment
- Becton, Dickinson and Company 2025 Q4 - Results - Earnings Call Presentation
- 1578 Partners initiates new position in Becton, Dickinson and Company in Q3
- Becton Dickinson outlines $200M cost reduction and targets $14.75–$15.05 EPS for 2026 while expanding sales force
Read the full article on Seeking Alpha
For further details see:
Waters raised to Outperform at Wolfe on BD Life Sciences deal
Waters Corporation
NASDAQ: WAT
WAT Trading
-1.01% G/L:
$284.73 Last:
349,636 Volume:
$285.48 Open:
WAT Latest News
March 09, 2026 08:00:00 am
Waters Flagship ARES?G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
WAT Stock Data
$19,462,563,078
58,952,201
0.08%
377
N/A
Biotechnology & Life Sciences
Healthcare
US
Milford
